Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry

M. Loebinger (London, United Kingdom), M. Loebinger (Dundee, United Kingdom), F. Ringshausen (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), P. Goeminne (AZ Nikolaas, Belgium), M. Murris (Toulouse, France), M. Vendrell (Girona, Spain), R. Menendez (Valencia, Spain), R. Wilson (London, United Kingdom), W. Boersma (Alkmaar, Netherlands), A. Hill (Edinburgh, United Kingdom), A. Torres (Barcelona, Spain), K. Dimakou (Athens, Greece), T. Welte (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), F. Blasi (Milan, Italy), S. Elborn (London, United Kingdom), E. Polverino (Barcelona, Spain), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)

Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session: The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session type: Poster Discussion
Number: 348
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Loebinger (London, United Kingdom), M. Loebinger (Dundee, United Kingdom), F. Ringshausen (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), P. Goeminne (AZ Nikolaas, Belgium), M. Murris (Toulouse, France), M. Vendrell (Girona, Spain), R. Menendez (Valencia, Spain), R. Wilson (London, United Kingdom), W. Boersma (Alkmaar, Netherlands), A. Hill (Edinburgh, United Kingdom), A. Torres (Barcelona, Spain), K. Dimakou (Athens, Greece), T. Welte (Hannover, Germany), A. De Soyza (Newcastle, United Kingdom), F. Blasi (Milan, Italy), S. Elborn (London, United Kingdom), E. Polverino (Barcelona, Spain), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom). Characteristics of patients with pulmonary non-tuberculous Mycobacterial infection in bronchiectasis: Data from the EMBARC registry. 348

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary non-tuberculous mycobacterial infection: 889 cases
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019

Clinical analysisof patients with pulmonary nontuberculous mycobacterial disease complicated with pneumothorax
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013

Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Mycobacterial non-tuberculosis infection in patients operated on for pulmonary tuberculosis
Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease
Year: 2020


Prevalence of nontuberculosis mycobacterial in patients with bronchiectasis: A meta-analysis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Screening non-tuberculous mycobacteria in patients with bronchiectasis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006



Treatment outcomes of non tuberculous mycobacterial (NTM) pulmonary disease. Multicenter study
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


Management of pulmonary nontuberculous mycobacteria disease
Source: Eur Respir Monogr 2018; 81: 222-237
Year: 2018


Pulmonary non-tuberculous mycobacterial infection (pNTM) with multiple species
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Nontuberculous mycobacterial co-infection in HIV-negative patients with pulmonary tuberculosis
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Cases series on nontuberculous mycobacterial (NTM) lung disease and silicosis in Brazil
Source: International Congress 2017 – Case reports and series
Year: 2017


Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009


Nontuberculous mycobacteria and aspergillus coexistence in pulmonary disease – Retrospective analysis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Pulmonary nontuberculous mycobacerial disease in elderly patients
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Nontuberculous mycobacteria in patients with bronchiectasis: data from the German Bronchiectasis Registry PROGNOSIS
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Pulmonary diseases due to non-tuberculous mycobacteria in TB referral clinical center
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007